Premium
EFFECT OF LISURIDE ON INHIBITION OF LACTATION AND SERUM PROLACTIN
Author(s) -
Cecco L.,
Venturini P. L.,
Ragni N.,
Rossato P.,
Maganza C.,
Gaggero G.,
Horowski R.
Publication year - 1979
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1979.tb10722.x
Subject(s) - lisuride , lactation , prolactin , chemistry , medicine , endocrinology , pharmacology , biology , bromocriptine , pregnancy , hormone , genetics
Summary Lisuride, a new semisynthetic ergot derivative, was given to 53 women to inhibit lactation; 26 women had 300 ug daily and 27 had 600 ug daily for seven days. Eight lactating women acted as controls. Lisuride effectively inhibited lactation and also suppressed the serum prolactin levels; the latter effect was dose related. Lisuride produced no untoward side effects.